Molecular mechanism (s) of regulation (s) of c-MET/HGF signaling in head and neck cancer

S Raj, KK Kesari, A Kumar, B Rathi, A Sharma… - Molecular cancer, 2022 - Springer
Head and neck cancer is the sixth most common cancer across the globe. This is generally
associated with tobacco and alcohol consumption. Cancer in the pharynx majorly arises …

Targeting cellular metabolism in head and neck cancer precision medicine era: A promising strategy to overcome therapy resistance

X Lin, W Zhou, Z Liu, W Cao, C Lin - Oral Diseases, 2023 - Wiley Online Library
Head and neck squamous cell carcinoma (HNSCC) is among the most prevalent cancer
worldwide, with the most severe impact on quality of life of patients. Despite the …

Tanshinone IIA inhibits oral squamous cell carcinoma via reducing Akt-c-Myc signaling-mediated aerobic glycolysis

M Li, F Gao, Q Zhao, H Zuo, W Liu, W Li - Cell Death & Disease, 2020 - nature.com
Aerobic glycolysis is one of the hallmarks of human cancer cells. Overexpression of
hexokinase 2 (HK2) plays a crucial role in the maintaining of unlimited tumor cell growth. In …

The glutaminase inhibitor telaglenastat enhances the antitumor activity of signal transduction inhibitors everolimus and cabozantinib in models of renal cell carcinoma

E Emberley, A Pan, J Chen, R Dang, M Gross… - PLoS …, 2021 - journals.plos.org
Dysregulated metabolism is a hallmark of cancer that manifests through alterations in
bioenergetic and biosynthetic pathways to enable tumor cell proliferation and survival …

Cancer-associated fibroblasts: Mediators of head and neck tumor microenvironment remodeling

M Raudenska, J Balvan, K Hanelova… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Cancer-associated fibroblasts (CAFs) are involved in critical aspects of head and neck
squamous cell carcinoma (HNSCC) pathogenesis, such as the formation of a tumor …

[HTML][HTML] Unveiling the Role of HGF/c-Met Signaling in Non-Small Cell Lung Cancer Tumor Microenvironment

S Yao, X Liu, Y Feng, Y Li, X **ao, Y Han… - International Journal of …, 2024 - mdpi.com
Non-small cell lung cancer (NSCLC) is characterized by several molecular alterations that
contribute to its development and progression. These alterations include the epidermal …

c-Met signaling as a therapeutic target in head and neck cancer

SM Centuori, JE Bauman - The Cancer Journal, 2022 - journals.lww.com
Despite a dearth of activating driver mutations in head and neck squamous cell carcinoma
(HNSCC), aberrant activation of the oncogenes, epidermal growth factor receptor (EGFR) …

PKM2 modulation in head and neck squamous cell carcinoma

V Boschert, J Teusch, UDA Müller-Richter… - International Journal of …, 2022 - mdpi.com
The enzyme pyruvate kinase M2 (PKM2) plays a major role in the switch of tumor cells from
oxidative phosphorylation to aerobic glycolysis, one of the hallmarks of cancer. Different …

Protein phosphatase 2A as a therapeutic target in small cell lung cancer

T Mirzapoiazova, G **ao, B Mambetsariev… - Molecular cancer …, 2021 - AACR
Abstract Protein phosphatase 2A (PP2A), a serine/threonine phosphatase involved in the
regulation of apoptosis, proliferation, and DNA-damage response, is overexpressed in many …

Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma

H Tada, H Takahashi, R Kawabata-Iwakawa… - Scientific Reports, 2020 - nature.com
The emergence of immune checkpoint inhibitors (ICIs) has revolutionized the treatment of
recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). Biomarkers …